Combinations of antibiotics against Pseudomonas aeruginosa

Insights

Pseudomonas aeruginosa infections are increasing, with high mortality. Combination antibiotic therapy, particularly aminoglycosides with beta-lactams, shows promise for treating these serious bacterial infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Pseudomonas aeruginosa causes severe infections, especially bacteremias, in hospitalized and immunocompromised patients.
  • The frequency of P. aeruginosa bacteremia has risen, with high mortality rates (up to 85%) despite treatment.
  • In vitro synergy testing's predictive value for P. aeruginosa is not firmly established, but in vitro synergy is crucial for guiding therapy selection.

Purpose of the Study:

  • To review the current evidence on combination antimicrobial therapy for serious Pseudomonas aeruginosa infections.
  • To identify effective antibiotic combinations for P. aeruginosa based on in vitro synergy and clinical outcomes.

Main Methods:

  • Review of available data on in vitro synergy testing for P. aeruginosa.
  • Analysis of experimental animal studies supporting combination therapy.
  • Evaluation of retrospective and prospective human studies on antimicrobial combinations.

Main Results:

  • In vitro synergy is often demonstrated with combinations of aminoglycosides (amikacin, tobramycin) and antipseudomonal beta-lactams.
  • Animal models support combination therapy for local and bacteremic P. aeruginosa infections.
  • Human studies suggest improved survival with combination therapy, especially in immunocompromised hosts.

Conclusions:

  • Combination therapy, particularly aminoglycosides with beta-lactams, is recommended for serious P. aeruginosa infections.
  • Preferred regimens include newer penicillins (piperacillin, azlocillin) or cephalosporins combined with amikacin or tobramycin.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...